Cargando…

Lysophosphatidic Acid Level and the Incidence of Silent Brain Infarction in Patients with Nonvalvular Atrial Fibrillation

Lysophosphatidic acid (LPA), which is proposed to play an important role in normal physiological situations such as wound healing, vascular tone, vascular integrity and reproduction, may be involved in the etiology of some diseases such as atherosclerosis, cancer, obesity or myocardial infarction. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhen-Guang, Yu, Zhan-Cai, Yu, Yong-Peng, Ju, Wei-Ping, Wang, Dao-Zhen, Zhan, Xia, Wu, Xi-Juan, Zhou, Li
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996775/ https://www.ncbi.nlm.nih.gov/pubmed/21152315 http://dx.doi.org/10.3390/ijms11103988

Ejemplares similares

The differences of atrial thrombus locations and variable response to anticoagulation in nonvalvular atrial fibrillation with ventricular cardiomyopathy
por: Zhang, Hao, et al.
Publicado: (2020)

Effects of Left Atrial Appendage Closure on Neuroendocrine Function in Patients with Nonvalvular Atrial Fibrillation
por: Wang, Fei, et al.
Publicado: (2022)

Silent brain infarcts impact on cognitive function in atrial fibrillation
por: Kühne, Michael, et al.
Publicado: (2022)

Right atrium thrombosis in nonvalvular permanent atrial fibrillation
por: Bălăceanu, A.
Publicado: (2011)

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014)

Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation
por: Cirincione, Brenda, et al.
Publicado: (2018)

Altered profile of circulating microparticles in nonvalvular atrial fibrillation
por: Siwaponanan, Panjaree, et al.
Publicado: (2019)

Clinical and Imaging Characteristics of Cerebral Infarction in Patients with Nonvalvular Atrial Fibrillation Combined with Cerebral Artery Stenosis
por: Sun, Wei, et al.
Publicado: (2018)

Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA(2)DS(2)-VASc score
por: Yan, Shuangbing, et al.
Publicado: (2019)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021)

Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
por: Yu, Yunan, et al.
Publicado: (2022)

Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation
por: Patel, Manesh R., et al.
Publicado: (2018)

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
por: Brown, Joshua D., et al.
Publicado: (2016)

Nationwide Study of Sex Differences in Incident Heart Failure in Newly Diagnosed Nonvalvular Atrial Fibrillation
por: Yogasundaram, Haran, et al.
Publicado: (2022)

Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands
por: Chen, Qingui, et al.
Publicado: (2023)

Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study
por: Li, Zhi-Zhao, et al.
Publicado: (2022)

Characteristics, Thrombus Resolution, and Long-Term Outcomes in Patients with Nonvalvular Atrial Fibrillation and Atrial Thrombus
por: Yang, Shu, et al.
Publicado: (2023)

Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism
por: Zheng, Jie, et al.
Publicado: (2021)

The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
por: Li, Hongxia, et al.
Publicado: (2021)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Nonvalvular atrial fibrillation in India—time to pause, think, and change!
por: Singh, Balbir
Publicado: (2018)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Massive Left Atrial Thrombi during Dabigatran Therapy for Nonvalvular Atrial Fibrillation
por: Bachvarova, Velislava, et al.
Publicado: (2017)

Endocardial Changes in Nonvalvular Atrial Fibrillation Without Atrial Thrombus—Thrombomodulin and Tissue Factor Pathway Inhibitor
por: An, Kang, et al.
Publicado: (2018)

Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study
por: Ajabnoor, Alyaa M., et al.
Publicado: (2022)

Short- and long-term outcomes of patients with minor stroke and nonvalvular atrial fibrillation
por: Duan, Chunmiao, et al.
Publicado: (2023)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
por: Zhou, Xue, et al.
Publicado: (2020)

Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation
por: Zhao, Mindi, et al.
Publicado: (2022)

Association of Heart Rate Variability With Silent Brain Infarcts in Patients With Atrial Fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2021)

Clinical Characteristics and Impact of Diabetes Mellitus on Outcomes in Patients with Nonvalvular Atrial Fibrillation
por: Huang, Bi, et al.
Publicado: (2015)

Whether Warfarin Therapy is Associated with Damage on Renal Function in Chinese Patients with Nonvalvular Atrial Fibrillation
por: Kong, Yu, et al.
Publicado: (2016)

Gender-related Differences in Management of Nonvalvular Atrial Fibrillation in an Asian Population
por: Lee, Jung Myung, et al.
Publicado: (2018)

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018)

Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study
por: De Vecchis, Renato, et al.
Publicado: (2019)

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)

Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease
por: Fukamachi, Daisuke, et al.
Publicado: (2022)

Evaluation of New Potential Inflammatory Markers in Patients with Nonvalvular Atrial Fibrillation
por: Martins, Gabriela Lopes, et al.
Publicado: (2023)

Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation
por: Biskupiak, Joseph, et al.
Publicado: (2013)

Health Care Burden of Dyspepsia Among Nonvalvular Atrial Fibrillation Patients
por: Kim, Michael H., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a3v486jv4agjnj9ssl0o2c16ol